Patent · US Active

Method for determining predisposition to pulmonary infection

US9133518B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

President and Fellows of Harvard College · US

Inventors

Hara Levy · Bayside, US
Craig Gerard · Dover, US
Gerald B. Pier · Brookline, US
Scott Weiss · Sharon, US
Christoph Lange · Berlin, DE

Key dates

Filing date	Nov 15, 2011
Grant date	Sep 15, 2015
Priority date	—
Expiry date	Nov 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods and materials for diagnosing a subject's predisposition for pulmonary infection in a CF subject by detecting a pulmonary infection genetic marker. Pulmonary infection markers have been identified in the IL-1 gene cluster and may be useful in predicting CF disease progression and assessing a CF subject's response to therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.